Regeneron Pharmaceuticals, Inc.
Anti-TMPRSS2 antibodies and antigen-binding fragments
Last updated:
Abstract:
The present invention includes an antibody or antigen-binding fragment thereof that binds specifically to TMPRSS2 and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., influenza virus infections).
Status:
Grant
Type:
Utility
Filling date:
24 Jan 2019
Issue date:
9 Mar 2021